prostate carcinoma (PCa) or ''intraductal carcinoma of the prostate'' (IDC-P) which is almost always associated with high-grade invasive PCa. HGPIN is a widely accepted putative PCa precursor, 6 however, recent data suggests patients with isolated HGPIN on needle biopsy have a similar risk of carcinoma on subsequent biopsy as patients with a benign diagnosis. 7 The concept of IDC-P was first proposed by McNeal and Yemoto in 1996, 17 and several studies have attempted to develop a comprehensive histologic definition for IDC-P in the last decade. 3, 4, 9 Notably, IDC-P has been reported to be associated with high Gleason score (GS), large tumor volume, extraprostatic extension of carcinoma, and accelerated disease progression in radical prostatectomy specimens. 14, 17, 26 Although the origin of IDC-P is not clear yet, recent clinical, immunohistochemical, and molecular studies suggested that IDC-P is a late event in carcinoma progression and most likely represents the intraductal spread of established PCa. 3, 5, 17 The distinction of IDC-P from HGPIN is critical, especially when observed on needle biopsies. Cohen et al 4 proposed 5 major criteria and 2 minor criteria to the diagnosis of IDC-P. Recently, Guo and Epstein 9 established a set of morphologic criteria on needle biopsies that define IDC-P as malignant cells filling large acini and prostatic ducts with at least partial preservation of basal cells forming either: (1) solid or dense cribriform patterns or (2) loose cribriform or micropapillary patterns with marked nuclear atypia (nuclear size 6 Â normal or larger) and/or comedonecrosis. Although this criterion is specific and objective, it is unclear how to interpret the cases that do not satisfy IDC-P criteria on needle biopsy. In a recent study aimed at understanding the morphologic differences between cribriform HGPIN and IDC-P, we observed that isolated ACL is uncommon, and the overwhelming majority of ACLs are associated with high grade (GSZ7) and high volume PCa, supporting that they represent spectrum of IDC-P. Even though several morphologic features were helpful in distinction of IDC-P from cribriform HGPIN, there were lesions that did not fully satisfy the published criteria for IDC-P yet were worse than typical HGPIN and were difficult to distinguish based on morphologic criteria alone. 29 Recently, we and others identified recurrent genetic rearrangements in PCa resulting in the fusion of androgen-regulated gene TMPRSS2 or other unique 5 0 fusion partner genes to ETS family members ERG, ETV1, ETV4, ETV5, and ELK4. 10, 13, 15, 25, [30] [31] [32] The most common fusion, TMPRSS2-ERG, is present in approximately 50% to 70% of prostate-specific antigen (PSA) screened localized PCa and in 15% to 30% of population-based cohorts. 33 By contrast, approximately B20% of the HGPIN lesions harbor TMPRSS2-ERG fusion. 2, 11, 23 Importantly, all HGPIN lesions with ERG rearrangement analyzed using fluorescence in-situ hybridization (FISH) also had intermingling carcinoma foci with ERG rearrangement.
11,23 TMPRSS2-ERG fusion was not observed in HGPIN lesions geographically distant to PCa, even if the PCa from the same individual demonstrated the TMPRSS2-ERG fusion. As TMPRSS2 and ERG are located B3 Mb apart on chromosome 21, the rearrangement between them occurs either through insertion or by an interstitial deletion (EDel). 22 Emerging data have suggested TMPRSS2-ERG fusion associated with EDel, resulting in a more aggressive phenotype in clinically localized and in androgen-independent metastatic PCa. 18, 21 Notably, duplication of TMPRSS2-ERG in combination with deletion of 5 0 -ERG (EDel 2+) was suggested to be an indicator of poor prognosis in PCa. Previously, we have shown that EDel 2+ occurred in 57% (4 of 7) of small cell carcinomas of the prostate. 12 In this study we aimed at understanding the molecular basis of 2 categories of ACLs and their relation to PCa by comprehensive FISH assessment of ETS gene aberrations. We characterized and compared the 2 categories of ACL for their associations with ETS status, clonality, and evolution stage in carcinoma progression and determined whether an ERG FISH assay would be helpful in the differentiation of IDC-P from cribriform HGPIN on needle biopsy. Immunohistochemistry for basal cell markers p63 and/or high molecular weight cytokeratin was performed on each select case as previously described to confirm the presence of basal cells. 27, 35 The primary antibodies and their dilutions were as follows: high molecular weight cytokeratin 1:200 (DAKO, Carpinteria, CA) and p63 1:200 (Labvision, Fremont, CA). ACL cases that were negative for basal cell markers were considered to represent cribriform PCa and were excluded from this study. Benign lesions with cribriform architecture without cytologic atypia, including central zone glands, basal cell hyperplasia, benign glands with inflammation, and cribriform clear cell hyperplasia were also excluded. ACLs with solid areas were included in this study. For each case total seven 5 mm serial sections were cut from paraffin block for analysis: the first and the seventh sections were used for hematoxylin and eosin staining to verify the presence of ACL under study and sections 2 to 6 were used for FISH screen.
MATERIALS AND METHODS
A total of 64 cases with ACLs met the criteria. All ACLs were reviewed by 3 pathologists (B.H., M.Z., and R.B.S.) and further divided into 2 categories similar to our previous study which focused on understanding the morphologic differences between IDC-P and cribriform HGPIN: ACL associated with PCa was admixed with or within 3 mm of the border of PCa (ACL-PCa), presumed to be spectrum of IDC-P and ACL not associated with PCa, or isolated ACL was more than 3 mm distant from the closest carcinoma in any single section and 4 mm from the closest carcinoma on the adjacent section above or below (isolated ACL), presumed to be isolated cribriform HGPIN based on findings from our previous study. 29 Both isolated cribriform HGPIN and IDC-P foci were present in 2 cases. All IDC-P cases were further divided into 2 categories: group A with marked nuclear atypia (nuclear size 6 Â normal or larger) and/or comedonecrosis as suggested by Guo and Epstein 9 and group B lesions which did not fulfill these morphologic criteria. The clinical and pathologic characteristics, along with followup information for PSA recurrence, were obtained from the Pathology Department database of University of Michigan Health System and Cleveland Clinic.
FISH and Assessment of ERG Rearrangement
Interphase FISH was performed as previously described. 10 Bacterial artificial chromosomes were obtained from the BACPAC Resource Center (Oakland, CA), and probes were prepared as described. 30 The integrity and correct localization of the probes was verified by hybridization to metaphase spreads of normal peripheral lymphocytes. For detection of ERG rearrangements, we used the following bacterial artificial chromosome clones as probes: RP11-95I21 (5 0 to ERG) and RP11-476D17 (3 0 to ERG), RP11-703A4 (5 0 to ETV1) and RP11-124L22 (3 0 to ETV1), RP11-436J4 (5 0 to ETV4) and RP11-100E5 (3 0 to ETV4), and RP11-379C23 (5 0 to ETV5) and RP11-1144N13 (3 0 to ETV5). Slides were examined using an Imaging Zeiss microscope (Carl Zeiss, Oberkochen, Germany) equipped with integrated software for imagers and spectrometers image processing software (Metasystems). FISH signals were scored manually (Â 100 oil immersion objective) in morphologically intact and nonoverlapping nuclei by 2 pathologists (B.H. and R.B.S), and a minimum of 50 carcinoma cells from each site were recorded. Carcinoma cells with very weak or no signals were recorded as insufficiently hybridized.
A previously validated break-apart probe FISH approach was used to investigate gene rearrangement involving ETS transcription factors (ERG, ETV1, ETV4, and ETV5). 10 Briefly, normal signal patterns for ETS family genes were indicated by 2 pairs of colocalized green and red signal, insertion was indicated by break apart of 1 of the 2 colocalized signals, and deletion was indicated by the loss of either one 5 0 or 3 0 signal. A duplication pattern of rearrangement was indicated as the presence of 2 or more 5 0 or 3 0 signals. ERG breakapart probes design and its interpretation is illustrated in Figure 1 .
Statistical Analysis
Chi-square test was used to test the significant difference of clinicopathologic features between analyzed groups, with P values<0.05 being considered statistically significant.
RESULTS
A dual-color break-apart FISH assay was used to validate 16 isolated cribriform HGPIN and 48 IDC-P cases for ETS gene aberrations on radical prostatectomy specimens. Of IDC-P cases, 19 (40%) fulfilled the classic criteria of IDC-P [marked nuclear atypia (nuclear size 6 Â normal or larger] and/or comedonecrosis] as suggested by Guo and Epstein, 9 and were designated as group A. Remaining 29 (60%) did not fulfill these criteria of IDC-P, designated as group B. Of note, the presence of minor component with histologically low-grade ACL was also noted in some cases of group A. Overall, ERG gene rearrangement was observed in 75% (36 of 48) of IDC-P, of which 64% (23 of 36) are through deletion and 36% (13 of 36) through insertion. Notably, EDel 2+ was identified in 17% (6 of 36) of the IDC-P in this cohort. Previously, EDel 2+ was reported to be present in 6.6% of localized PCa cases, with extremely poor prognosis. 1 Our Figure 2 and Figure 3 respectively.
Overall, 78% (15 of 19) of group A and 72% (21 of 29) of group B IDC-P demonstrated ERG gene rearrangement. EDel 2+ was identified in 20% (3 of 15) of group A and 14% (3 of 21) of group B IDC-P. Although the prevalence of ERG aberrations was slightly higher among group A as compared with the latter (78% vs. 72%), there was no significant difference between these 2 groups with respect to ERG gene aberrations. Figure 2 summarizes ERG gene rearrangement status in this cohort.
Next, we explored whether clinicopathologic features differ between ERG rearranged and ERG not rearranged IDC-P cases (Table 1) and between groups A and B of IDC-P. As shown in Table 1 , there was no significant differences of pathology outcomes between ERG rearranged versus ERG not rearranged cases (P>0.05). For comparisons between groups A and B IDC-P cases, there was a trend toward group A (IDC-P) patients being more likely to have extraprostatic extension involvement (74% vs. 50%, P = 0.09). However, there was no statistically significant difference between these 2 groups regarding GS, tumor size, tumor stage, seminal vesicle invasion, surgical margins, and PSA recurrence (P>0.05).
To further characterize the relationship of IDC-P and adjacent carcinoma, we interrogated paired IDC-P and adjacent invasive carcinoma foci from 33 cases for assessment of ERG gene aberration. As expected, 100% (33 of 33) of the cases were concordant with presence of ERG gene rearrangements or concordant by lack of ERG gene rearrangement in any tumor foci. These data support IDC-P being clonally related to the adjacent carcinoma foci. In this series, there were 2 multifocal PCa cases with IDC-P that also had lymph node metastasis. Of note, in both cases, ERG rearrangement (5 0 deletion) was identified in IDC-P, adjacent invasive carcinoma, and the lymph node metastasis, but was absent in another separate carcinoma focus. Figure 4 demonstrated ERG status in one such case.
DISCUSSION
To date, TMPRSS2-ERG gene fusion has been demonstrated as a specific PCa biomarker with potential applications for early diagnosis and management. 16, 28, 33 Evidence supporting this notion is that in contrast to the high prevalence reported in clinically localized PCa, TMPRSS2-ERG gene fusion is not identified in benign prostatic tissue by FISH, and is detected only in a subset of HGPIN lesions. 16, 28, 33 Importantly, TMPRSS2-ERG gene fusion in HGPIN is never an isolated phenomenon and almost always present in close proximity of fusionpositive carcinoma foci, suggesting fusion-positive HGPIN is a precursor lesion to PCa bearing the same genetic aberration. 2, 11, 23 As cribriform HGPIN and IDC-P connote drastically different clinical significance, it is critical to distinguish the two, especially in the setting of prostate needle biopsy. Several recent studies put forward diagnostic criteria for IDC-P 4,9 based on architectural and/or cytologic characteristics. Most recently, we comprehensively analyzed 117 radical prostatectomy specimens and studied the morphology spectrum and topographic relation of isolated ACL versus ACL-PCa. 29 We observed that in comparison to isolated ACL, the overwhelming majority of ACL-PCa was associated with high Gleason grade (GSZ7) and high volume of PCa, supporting that they represent a spectrum of IDC-P. Several morphologic features, such as notably large gland size (>1 mm), large focus involving many glands (n>6), complex architecture, and high-grade nuclei were characteristic of IDC-P. However, there were lesions that did not fully satisfy the criteria for IDC-P yet were worse than typical HGPIN and overlapped at ''low-grade'' morphologic spectrum. There have been attempts to understand differential genetic aberration and immunohistochemical staining between IDC-P and HGPIN. Dawkins et al 5 reported that loss of heterozygosity was infrequent in HGPIN (9%), but common in IDC-P (60%). However, very few of them could be used for clinical practice. We hypothesized that ETS gene fusion could be helpful in this setting as a genetic biomarker. In this study, for the first time, we took a different approach to comprehensively investigate ACL of the prostate with ETS aberrations based on their topographic relationship to invasive carcinoma. Four noteworthy observations were made through the comprehensive ETS FISH screen.
First, only ERG gene rearrangements were identified in this cohort, suggesting that similar to conventional PCa, ETV1, ETV4, or ETV5 gene fusions are very rare in IDC-P of the prostate. As described previously, 10 we used ERG gene rearrangement status as an indicator for TMPRSS2-ERG fusion, as only SLC45A3 and NDRG1 have been identified as additional 5 0 fusion partners of ERG. 10, 24 As both SLC45A3-ERG and NDRG1-ERG are very rare in PSA-screened radical prostatectomy series, we can conclude that most of the ERG rearranged ACL in this study are TMPRSS2-ERG fusions (>97%).
Second, ERG rearrangement frequency was markedly different in isolated cribriform HGPIN lesions versus IDC-P. Of note, all isolated high-grade cribriform HGPIN in this cohort lacked ERG gene rearrangement, whereas it was present in 75% of IDC-P. This finding provides the convincing evidence that IDC-P and isolated cribriform HGPIN are genetically distinct. Histologically, none of the isolated cribriform HGPIN showed largecalibre branching glands, markedly enlarged nuclei, or comedonecrosis. Although the possibility of the presence of IDC-P in isolated ACL cannot be entirely excluded, our data strongly suggested that most of the isolated ACL likely represent cribriform HGPIN. Indeed, Wilcox et al 34 reported that only in 1 out of 252 patients, the IDC-P of cribriform type was completely separated from invasive carcinoma foci. Although the prevalence of ERG rearrangement in isolated cribriform HGPIN on needle biopsies is currently unknown, we hypothesized that this would be very rare (<5%) and the presence of ERG rearrangement would indicate adjacent invasive carcinoma that was missed by biopsy. By contrast, ERG rearrangement was identified to be intriguingly enriched in IDC-P. Previously, cribriform growth pattern of PCa has been reported to be one of the morphologic features associated with ERG fusion status both on radical prostatectomy and needle biopsy specimens. 19, 20 In line with our findings, Cohen et al 4 has suggested that morphologic feature of IDC-P was significantly associated with TMPRSS2-ERG gene fusion. Interestingly, for the first time, we found that EDel2+ is not infrequent in IDC-P. EDel 2+ was suggested to be an indicator of very poor prognosis in PCa and reported to be present in 6% of localized carcinomas. 1 We have shown that EDel 2+ occurred in 57% (4 of 7) of small cell carcinomas of the prostate. 12 These findings suggested that isolated cribriform HGPIN and IDC-P are biologically distinct lesions and IDC-P is associated with a more aggressive phenotype. This notion is also supported by our recent morphologic study, in which we found that most of the IDC-P are associated with high-tumor grades (GS>7) and high tumor volume, whereas isolated cribriform HGPIN is not. 29 Third, there was no significant difference of ERG gene aberrations between 2 different histologic groups of IDC-P. Group A in this cohort characterized by marked nuclear atypia (nuclear size 6 Â normal or larger) and/or comedonecrosis represents classic morphologic pattern of IDC-P, which can be recognized on needle biopsy with sufficient reliability. By contrast, group B IDC-P represents low-grade morphology with significant overlap between cribriform HGPIN and IDC-P. Of note, these 2 lesions may be indistinguishable morphologically. 34 Interestingly, a high prevalence (>70%) of ERG rearrangement was identified in group B lesions of IDC-P. If this group of IDC-P with low-grade histology represented HGPIN, one would expect the prevalence of ERG rearrangement would be closer to the B20% reported in HGPIN. 11, 23 Therefore, our data, for the first time, suggests that the majority of ACL-PCa with low-grade histologic features in fact represent IDC-P with low-grade histologic spectrum, rather than cribriform HGPIN. This is further supported by two other observations. First, the prevalence of Edel2+ was not significantly different between high and low-histologic grade IDC-P (20% vs. 14%). Second, a comparison of clinicopathologic features between these two groups showed no significant difference in GS, tumor size, tumor grade, or PSA recurrence, suggesting that IDC-P with low-grade histology is similar to high-histologic grade IDC-P in its biologic characteristics.
Fourth, 100% of the IDC-P in this cohort showed concordance of ERG gene rearrangement with related invasive carcinoma foci, suggesting that IDC-P is clonally related to the latter. These results are concordant with both hypotheses of evolution of IDC-P, that is, intraductal spread of a nearby invasive carcinoma or rarely develops from a de novo growth, as cases of IDC-P with no invasive PCa component have been reported. 8 Of note, in 2 ERG rearranged cases of IDC-P with regional lymph node metastases, the ERG status in the metastasis was concordant with the tumor focus containing IDC-P component, but discordant with an additional second tumor lacking IDC-P. This finding suggested that in these 2 cases, ERG fusion-positive PCa containing IDC-P may be more biologically aggressive than other tumor foci lacking IDC-P from the same individual. It remains possible that IDC-P evolves from HGPIN, a hypothesis that could not be addressed by this study. However, our study does demonstrate that IDC-P and HGPIN are genetically distinct, even though they may have overlapping histologic features.
On the basis of these results, assessment of ERG rearrangement by FISH may provide valuable information in the workup of ACL without concurrent invasive carcinoma on needle biopsy. For an ACL regardless of the morphologic features, the presence of ERG rearrangement would suggest the presence of adjacent carcinoma that was not sampled as isolated HGPIN without concurrent invasive carcinoma has not been reported yet. If an ACL morphologically lacks marked nuclear atypia or comedonecrosis, the presence of ERG rearrangement would strongly suggest it most likely represents IDC-P of low-grade histologic spectrum. These 2 situations should prompt immediate rebiopsy. On the other hand if an ACL with low-grade histology lacks ERG rearrangement, one cannot confidently rule out HGPIN as 20% to B30% of IDC-P is negative for any ETS gene fusions in this study. In this case rebiopsy is still strongly recommended if the overall morphology of ACL is suspicious for IDC-P of low-grade spectrum.
In summary, for the first time, using assessment of ERG aberration status, we demonstrate that IDC-P and cribriform HGPIN are biologically different lesions and this approach can be used to differentiate these lesions in biopsy. This molecular data provides further support to the morphologic observation that isolated cribriform HGPIN is uncommon and majority of ACL with lowgrade histology likely represents intraductal spread of invasive carcinoma. Together a combination of ERG break-apart FISH and current histologic assessment of IDC-P on needle biopsy will likely improve the diagnostic accuracy of these lesions.
